Earnings Ahead

SYBX - Synlogic Inc ~ Mirna Therapeutics Inc

0.4847 0.0657 15.68

Synlogic Inc ~ Mirna Therapeutics Inc

Synlogic Inc ~ Mirna Therapeutics Inc

About

Profile


Headquarters

Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

SYBX

Recent Earnings

Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M
  • Synlogic shares crater amid company shut down, failed drug study
  • Synlogic to discontinue lead drug program, cease operations
  • Synlogic provides corporate update, outlook for 2024
  • Synlogic bags contract to develop live probiotic products
  • Synlogic GAAP EPS of -$2.57 misses by $0.01, revenue of $0.39M beats by $0.31M
  • Synlogic earns $2.5 million milestone payment from Roche collaboration
  • Synlogic down 4%, priced $21M offering
  • Synlogic announces 1-for-15 reverse stock split
  • Synlogic GAAP EPS of -$0.21
  • Synlogic spikes on FDA Fast Track tag for metabolic disorder therapy
  • Synlogic GAAP EPS of -$0.23 in-line, revenue of $0.17M beats by $0.03M
  • Synlogic adds 23% on FDA orphan drug status for metabolic disease drug
  • Synlogic GAAP EPS of -$0.24 beats by $0.02, revenue of $0.11M misses by $0.12M
  • Synlogic's metabolic disorder therapy gets EMA backing for orphan drug tag
  • Synlogic rises ~10% as metabolic disorder drug gets FDA rare pediatric disease status
  • Synlogic GAAP EPS of -$0.25 misses by $0.02, revenue of $0.7M beats by $0.61M
  • Synlogic gains after early Phase 2 data for phenylketonuria candidates
  • Synlogic gets milestone payment under Roche pact to discover synthetic biotic for bowel disease
  • Synlogic's metabolic disorder drug gets FDA fast track status
PEERS
Recent Earnings

Synlogic GAAP EPS of -$1.71 misses by $0.74, revenue of $2.77M beats by $0.04M

Earnings History

Date EPS / Forecast Revenue / Forecast
November 10, 2021 -0.29 / -0.2867 916K / 128.57K Beat!
August 12, 2021 -0.28 / -0.3083 246K / 33.33K Beat!
May 13, 2021 -0.36 / -0.3867 - / -
March 25, 2021 -0.39 / -0.4029 - / -
November 5, 2020 -0.36 / -0.4629 - / -
August 6, 2020 -0.44 / -0.46 445K / 218.13K Beat!
May 8, 2020 -0.46 / -0.43 100K / 382.14K
March 12, 2020 -0.37 / -0.44 1.23M / 524.29K
November 12, 2019 -0.39 / -0.47 305K / 389.29K
August 8, 2019 -0.45 / -0.49 400K / 732.88K
May 9, 2019 -0.51 / -0.54 338K / 349.88K
March 12, 2019 -0.47 / -0.54 111K / 215.86K
November 13, 2018 -0.43 / -0.63 1.8M / 204.4K
August 8, 2018 -0.59 / -0.53 254K / 228.75K Beat!
May 15, 2018 -0.55 / -0.76 354K / 137K Beat!
March 12, 2018 - / -0.77 - / 105.5K
November 9, 2017 -1.66 / -0.5 111.0K / - Beat!
August 4, 2017 -3.08 / -0.5 2.22M / - Beat!
May 11, 2017 - / -0.1 - / -
March 15, 2017 -0.21 / -0.19 - / -
November 11, 2016 -0.26 / -0.36 - / -